EPISKIN organized its 1st international seminar in Lyon on June, 22 and 23, 2017.
122 scientists from around the world: industry, academics, regulatory authorities, CROs, partners and customers reviewed the state of the art of reconstructed biological tissue models and discussed the future prospects of these tools for the suppression of animal testing and the predictive evaluation of the efficacy or safety of chemicals in humans.
After an introduction by Nathalie SEYLER, CEO of EPISKIN, the sessions were organized on the very varied themes: Alternative methods and 3D models; Eye irritation; Sensitization ; Phototoxicity; Genotoxicity; Medical devices ; New 3D models and 3D models at the heart of innovation.
Discover these two days of sharing and passion in this video clip: